Advertisement

The Scientist

» cancer and evolution

Most Recent

image: Legislating Negative Result Reporting

Legislating Negative Result Reporting

By | May 7, 2012

A new bill aims to increase transparency in cancer clinical trials by requiring researchers to divulge all outcomes.

2 Comments

image: Nervous Mice Get Worse Cancer

Nervous Mice Get Worse Cancer

By | May 3, 2012

Anxious mice are more likely to come down with aggressive skin cancer than those who show less stress on behavioral tests.

0 Comments

image: A New Branch of Life?

A New Branch of Life?

By | May 1, 2012

Researchers investigate a microorganism that may warrant a new eukaryotic kingdom in the classification of life.

4 Comments

image: Spot the Moth

Spot the Moth

By | May 1, 2012

It’s a well-known story: The peppered moth’s ancestral typica phenotype is white with dark speckles. 

0 Comments

image: Telomere Basics

Telomere Basics

By | May 1, 2012

Telomeres are repetitive, noncoding sequences that cap the ends of linear chromosomes. They consist of hexameric nucleotide sequences (TTAGGG in humans) repeated hundreds to thousands of times. 

4 Comments

image: Burgers and Flies

Burgers and Flies

By | May 1, 2012

Inspired by Darwin, Mohamed Noor has uncovered the molecular dance by which a single species becomes two.

10 Comments

image: Capsule Reviews

Capsule Reviews

By | May 1, 2012

Masters of the Planet, Learning from the Octopus, Darwin’s Devices, and Psychology’s Ghosts

2 Comments

image: Designing Transition-State Inhibitors

Designing Transition-State Inhibitors

By | May 1, 2012

A transition-state mimic has the power to bind an enzyme at its tipping point as strongly as any available inhibitor and more strongly than most, preventing enzymatic activity. 

0 Comments

image: Tumor Turnabout

Tumor Turnabout

By | May 1, 2012

A cytokine involved in suppressing the immune system may actually activate it to kill cancer cells.

4 Comments

image: Freezing Time

Freezing Time

By | May 1, 2012

Targeting the briefest moment in chemistry may lead to an exceptionally strong new class of drugs.

15 Comments

Advertisement

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
Advertisement
The Scientist